Press release - 11/03/2026 Blood Marker for Alzheimer’s May also Be Useful in Heart and Kidney Diseases A certain blood protein regarded as an early indicator of Alzheimer’s disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie Institute for Clinical Brain Research (HIH) at the University of Tübingen have found that elevated levels of phosphorylated tau protein (pTau) also occur in two lesser-known conditions that primarily affect the heart and kidneys.https://www.gesundheitsindustrie-bw.de/en/article/press-release/blood-marker-alzheimers-may-also-be-useful-heart-and-kidney-diseases
Press release - 09/03/2026 Early detection contributes to declining breast cancer mortality rates in Europe The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the DKFZ. The most striking finding: after the introduction of screening, significantly more early-stage, less advanced tumors were detected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-detection-contributes-declining-breast-cancer-mortality-rates-europe
Climate protection is health protection - 26/02/2026 Planetary health: advancing human health in the era of climate change Heatwaves, deteriorating air quality and extreme weather events are reshaping our living conditions. The climate and environmental crisis represent one of the greatest threats to human health. Are we prepared? Adaptation strategies, heat action plans and public education are essential to protecting health in a changing climate.https://www.gesundheitsindustrie-bw.de/en/article/news/planetary-health-advancing-human-health-era-climate-change
Press release - 18/02/2026 3D microtumors could revolutionize treatment decisions Chemotherapy is often a central component of treatment for advanced colorectal cancer. However, not every therapy is equally effective for every patient. Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* stem cell institute, and the biotech company Xilis in Utrecht, Netherlands, have now developed a new method for selecting the most effective drug before treatment begins. https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-microtumors-could-revolutionize-treatment-decisions
Press release - 18/02/2026 Shingles vaccination could slow cognitive decline New findings indicate that a shingles vaccination could not only reduce the risk of cognitive impairment and dementia, but also reduce disease progression among those living with dementia. https://www.gesundheitsindustrie-bw.de/en/article/press-release/shingles-vaccination-could-slow-cognitive-decline
Press release - 17/02/2026 Tracing Tumors in Cerebrospinal Fluid: A New Opportunity for Precision Diagnostics in Brain Tumors In a published scientific study, researchers have succeeded in accurately diagnosing common types of brain tumors in children and adolescents based on tumor-derived genetic material in cerebrospinal fluid. Until now, these so-called liquid biopsies were not capable enough for such reliable diagnostics. The international research team has therefore optimized a sequencing technique and developed an AI-based computational method. In a later step,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/tracing-tumors-cerebrospinal-fluid-new-opportunity-precision-diagnostics-brain-tumors
Press release - 10/02/2026 CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System CorTec GmbH, a pioneer in active implantable medical technologies, announced the successful second implantation of its proprietary Brain-Computer Interface system in a clinical trial. The implantation follows neurological gains observed in the study’s first participant. This represents another key milestone to evaluate CorTec’s fully implantable closed-loop BCI platform for therapeutic applications.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cortec-announces-successful-second-human-implantation-its-brain-computer-interface-bci-system
Press release - 06/02/2026 nanodiag BW receives funding for second implementation phase nanodiag BW has received approval from the BMFTR for a further three-year implementation phase under the Clusters4Future initiative. With the approval of €15 million, the innovation network will be able to continue its work on nanopore-based diagnostic methods seamlessly from April 2026 onwards. The Baden-Württemberg Ministry of Economic Affairs, Labour and Tourism is supporting the cluster management through accompanying measures.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanodiag-bw-receives-funding-second-implementation-phase
Press release - 22/01/2026 NAKO study confirms link between smoking and depression A research group led by the Central Institute of Mental Health in Mannheim has confirmed for the first time within the German National Cohort an association between cigarette consumption and depression. The findings show that depression occurs more frequently over the lifetime of current and former smokers than among those who have never smoked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/nako-study-confirms-link-between-smoking-and-depression
Press release - 22/01/2026 Knowledge Connector: better clinical decisions in molecular precision oncology Researchers at the National Center for Tumor Diseases (NCT) Heidelberg and the German Cancer Research Center (DKFZ) have developed a digital tool that significantly accelerates and improves clinical decisions in molecular precision oncology. The Knowledge Connector enables the structured and standardized evaluation of very extensive molecular tumor profiles and makes them available for personalized therapy decisions faster than before.https://www.gesundheitsindustrie-bw.de/en/article/press-release/knowledge-connector-better-clinical-decisions-molecular-precision-oncology
Press release - 16/01/2026 Hellstern medical’s Robotic Surgeon Assist Accepted into NATO DIANA for Security-Critical Key Technologies — Strategic Funding Secured At a time of geopolitical tensions and growing supply shortages, surgical capability is becoming a critical factor for resilient health systems. Hellstern medical GmbH has been accepted into the NATO DIANA innovation program with its key technology, the Robotic Surgeon Assist noac — NATO’s accelerator for defense and dual-use technologies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hellstern-medicals-robotic-surgeon-assist-accepted-nato-diana-security-critical-key-technologies-strategic-funding-secured
Press release - 16/12/2025 New measures to make EU health sector more innovative, competitive and resilient The European Commission has today proposed an ambitious package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the health sector.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-measures-make-eu-health-sector-more-innovative-competitive-and-resilient
Press release - 08/12/2025 New mutation catalog facilitates personalized cancer therapy When gene mutations are found in the tumor of cancer patients, it is often unclear whether they promote tumor growth or whether a targeted therapy could be effective. A research team led by the Medical Center - University of Freiburg has now compiled a catalog in which over 11,000 gene variants of a central gene family were examined and evaluated for their role in tumor growth. https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-mutation-catalog-facilitates-personalized-cancer-therapy
Between conservative and surgical intervention - 04/12/2025 Innovative tubular prosthesis enables reversible treatment for type 2 diabetes Severe obesity is considered a major cause of type 2 diabetes. Building on gastric bypass surgery, the Mannheim-based company Trans-Duodenal Concepts has developed an endoscopically implantable tubular prosthesis that lines the duodenum. This both reduces food intake and can restore normal blood sugar metabolism.https://www.gesundheitsindustrie-bw.de/en/article/news/innovative-tubular-prosthesis-enables-reversible-treatment-type-2-diabetes
Dossier - 20/11/2025 Prevention as the key to health Many serious illnesses can be prevented or at least mitigated through healthy lifestyles and early diagnosis. However, effective prevention requires holistic approaches at all levels of healthcare and the reinforcement of individual health literacy.https://www.gesundheitsindustrie-bw.de/en/article/dossier/prevention-key-health
Press release - 13/11/2025 New Initiative: Light for Public Health Light affects how we sleep, feel, and perform – yet public awareness of its impact remains limited. The Light for Public Health initiative aims to make evidence-based knowledge on light and health both accessible and actionable, thus turning scientific insight into public benefit.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-initiative-light-public-health
Press release - 07/11/2025 How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging. The scientist from the DKFZ-Hector Cancer Institute is the winner of the Falling Walls Foundation's “Breakthrough of the Year 2025” award in the Women's Impact category.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biological-clock-ticks-female-reproductive-tract-breakthrough-year-award-2025-angela-goncalves
Press release - 07/11/2025 Overcoming Tumor Resistance to Immunotherapy: The European Research Council awards international project led by Heidelberg Medical Faculty In the PRECISION-ImmunoRad project, a multidisciplinary team of scientists from Heidelberg, USA, and Cyprus will unite their expertise to develop novel curative therapeutic strategies for currently hard-to-treat cancers. These strategies will integrate high-precision ion beam therapy with genetically engineered immune cells therapies (CAR-T cells), personalized cancer vaccines, and the targeted reprogramming of the tumor immune microenvironment. https://www.gesundheitsindustrie-bw.de/en/article/press-release/overcoming-tumor-resistance-immunotherapy-european-research-council-awards-international-project-led-heidelberg-medical-faculty
Artificial intelligence: opportunities for healthcare - 06/11/2025 More than just deskwork: opportunities and obstacles for generative AI in healthcare Generative artificial intelligence (GenAI) has enormous potential in healthcare, ranging from automating time-consuming deskwork to supporting diagnoses. It is not just for the big players; there are also cost-effective ways for smaller companies and institutions to utilize GenAI.https://www.gesundheitsindustrie-bw.de/en/article/news/more-just-deskwork-opportunities-and-obstacles-generative-ai-healthcare
Press release - 05/11/2025 Novel Technique Improves Brain-State Detection Researchers have developed a new method that greatly improves the accuracy of brain-state classification with functional near-infrared spectroscopy (fNIRS). The brain-imaging technique fNIRS allows researchers to measure neural activity: Active brain cells need more oxygen, so variations in blood flow and oxygen saturation indicate which brain regions are at work. fNIRS detects these changes safely and without invasive procedures.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-technique-improves-brain-state-detection
Press release - 04/11/2025 Brain Tumor Charity supports immunotherapy for childhood brain tumors with 1.5 million pounds sterling Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the KiTZ, the DKFZ, the MFHD and UKHD have received a grant of 1.5 million pounds sterling (GBP) from the British organization The Brain Tumor Charity to develop a new type of immunotherapy for ependymoma.https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-tumor-charity-supports-immunotherapy-childhood-brain-tumors-15-million-pounds-sterling
Press release - 28/10/2025 AI solutions from the DKFZ set new standards in medical image processing Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year's world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support and follow-up care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-solutions-dkfz-set-new-standards-medical-image-processing
Press release - 27/10/2025 OnkoAktiv receives Cancer Innovation Award 2025 The nationwide OnkoAktiv network, founded at the National Center for Tumor Diseases (NCT) in Heidelberg, has been awarded the Baden-Württemberg Cancer Innovation Prize 2025. The prize recognizes OnkoAktiv for its pioneering role and groundbreaking contribution to the integration of exercise into oncological care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/onkoaktiv-receives-cancer-innovation-award-2025
Press release - 24/10/2025 Freiburg coordinates national early warning system on animal influenza viruses Federal government awards 3.5 million euros in funding to the collaborative research project FLU-PREP. Researchers are developing methods to identify the pandemic potential of new viruses at an early stage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-coordinates-national-early-warning-system-animal-influenza-viruses
Press release - 16/10/2025 ZEW Mannheim To Develop Research on Health Care Markets in the Digital Age The committee of the Joint Science Conference of the federal government and federal states in its meeting cleared the way for the application submitted by ZEW Mannheim for a research programme focusing on the implications of the digital transformation for the analysis and the design of digital health care markets. This paves the way for an expansion of the Institute's activities by establishing an independent health economics research unit. https://www.gesundheitsindustrie-bw.de/en/article/press-release/zew-mannheim-develop-research-health-care-markets-digital-age